Tong Ren Tang Technology (01666): Feng Zhimei has been appointed as an executive director.
Zhitong Finance and Economics APP reported that Tong Ren Tang Technology (01666) announced that, effective June 12, 2024, (i) Di Shubing, Chen Jiafu and Feng Zhimei were appointed as executive directors of the ninth Board of Directors; (ii) Zhang Yi, Wang Chunrui and Feng Li were appointed as non-executive directors of the ninth Board of Directors; and (iii) Chen Qingxia, Zhan Yuanjing, and Li Zhaobin were appointed as independent non-executive directors of the ninth Board of Directors. Effective June 12, 2024, Guo Wen and Wu Yigang were appointed as shareholder representative supervisors of the ninth Supervisor Board. At the same time, the workers' representative group held on May 14, 2024
TONG REN TANG: POLL RESULTS OF 2023 ANNUAL GENERAL MEETING HELD ON WEDNESDAY, 12 JUNE 2024; APPOINTMENT OF MEMBERS OF THE NINTH SESSION OF THE BOARD AND THE NINTH SESSION OF THE SUPERVISORY COMMITTEE; APPOINTMENT OF MEMBERS OF THE SPECIAL C...
The Five-year Shareholder Returns and Company Earnings Persist Lower as Tong Ren Tang Technologies (HKG:1666) Stock Falls a Further 5.5% in Past Week
Tong Ren Tang Technologies Co. Ltd. (HKG:1666) shareholders should be happy to see the share price up 14% in the last month. But if you look at the last five years the returns have not been good.
Tong Ren Tang Technology (01666) will pay a final dividend of $0.18 per share on August 9
According to Zhitong Finance App, Tong Ren Tang Technology (01666) announced that the company will pay a final dividend of RMB 0.18 per share on August 9, 2024.
TONG REN TANG: NOTICE OF ANNUAL GENERAL MEETING
Tong Ren Tang Technology (01666) proposes to appoint Zhang Yi as a non-executive director
Tong Ren Tang Technology (01666) announced that since the term of the 8th board of directors will expire at the end of the annual general meeting of shareholders, Dong...
Tong Ren Tang Chinese Medicine Appoints CEO
Tong Ren Tang Chinese Medicine (HKG:3613) has appointed Wang Chi as its new chief executive officer, effective May 10, according to a filing with Hong Kong Exchange last Friday. The acting CEO Chen Fe
Subdued Growth No Barrier To Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Price
It's not a stretch to say that Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) price-to-earnings (or "P/E") ratio of 10.7x right now seems quite "middle-of-the-road" compared to the market in Hong K
同仁堂科技:年報2023
Stable sector+product space, Tongrentang Technology (01666.HK)'s dual market potential
As we all know, in the Hong Kong stock market, Chinese medicine stocks have been undervalued for a long time. Judging from the net market ratio, the net market ratio of the entire traditional Chinese medicine concept is less than 1 times. A large part of the reason behind this is that investors in the Hong Kong stock market, especially foreign investors, have long had no understanding of traditional Chinese medicine or traditional Chinese medicine, and even misunderstood the introduction of animals and plants into medicine.
Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Tong Ren Tang Technologies Co. Ltd. Non-GAAP EPS of C$0.43, Revenue of C$23.89M
Tung Yan Tong Technology Announces 2023 Annual Results
BEIJING, MARCH 25, 2024 /NEWS MEDIA/ -- BEIJING TONGRENTANG TECHNOLOGY DEVELOPMENT CO., LTD. (“TONG YANTANG TECHNOLOGY” OR THE “GROUP”, 1666.HK) IS PLEASED TO ANNOUNCE THE GROUP'S AUDITED CONSOLIDATED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2013. In 2013, the Group achieved revenues of RMB67.7 billion, an increase of 13.04% year-on-year; achieved net net income of RMB5.9 billion, an increase of 1.25% year-on-year; in terms of products, the Group sold 62 products of more than RMB 500 million and sales of more than RMB 1 billion.
Good sector+performance catalyst, explaining in detail the differences in Tongrentang Technology (01666.HK)'s dual market expectations
Under a series of favorable policies, Tong Ren Tang Technology, as a highly recognizable and even scarce enterprise in the Hong Kong stock market, will benefit.
Tongrentang Technology (01666.HK)'s 2023 revenue of 6.773 billion yuan increased 13.04% year-on-year
Gelonghui, March 22丨Tong Ren Tang Technology (01666.HK) announced that for the year ended December 31, 2023, the Group's revenue was RMB 6.773 billion, up 13.04% year on year; net profit attributable to company owners was RMB 590 million, up 1.25% over the same period last year; earnings per share was RMB 0.46 (2022: RMB 0.46); and dividend per share was RMB 0.18 (2022: RMB 0.16). Throughout the year, the Group is committed to adapting to the new normal in the traditional Chinese medicine industry, continuing to focus on core competitive advantages, and advancing
Tongrentang Technology (01666) announced annual results. Profit attributable to shareholders of 590 million yuan increased 1.25% year-on-year, and final dividend of 0.18 yuan per share
Tong Ren Tang Technology (01666) announced its annual results for the year ended December 31, 2023. The group obtained revenue of RMB 6.773 billion (same unit), an increase of 13.04% year on year; profit attributable to company owners of RMB 590 million, an increase of 1.25% year on year; earnings per share of 0.46 yuan, and plans to pay a final dividend of RMB 0.18 per share.
TONG REN TANG: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
TONG REN TANG: ANNOUNCEMENT ON RESULTS OF SUBSIDIARY; AND REVISED DIVIDEND POLICY OF SUBSIDIARY
Tong Ren Tang Technology (01666.HK) held a board meeting on March 22 to consider and approve the annual results
Tong Ren Tang Technology (01666.HK) announced that the board meeting will be held on March 22, 2024 (Friday) at No. 20, South Third Ring Road, Fengtai District, Beijing, People's Republic of China.
TONG REN TANG: NOTICE OF BOARD MEETING
No Data